BMSSC
KRTX

B. Metzler seel. Sohn & Co’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,014
Closed -$1.27M – 786
2023
Q4 		$1.27M Buy
4,014
+2,398
+148% +$466K 0.02% 455
2023
Q3 		$273K Sell
1,616
-1,812
-53% -$341K ﹤0.01% 657
2023
Q2 		$743K Buy
+3,428
New +$734K 0.01% 528

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

B. Metzler seel. Sohn & Co's KRTX Position: Q1 2024 in Review

B. Metzler seel. Sohn & Co sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,014 shares — an estimated $1.27M sold.

B. Metzler seel. Sohn & Co first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $1.27M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • B. Metzler seel. Sohn & Co reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 4,014 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.27M.
  • B. Metzler seel. Sohn & Co first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • B. Metzler seel. Sohn & Co's Karuna Therapeutics, Inc. Common Stock position peaked at $1.27M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2024, filed 15 May 2024.